(
CHARTPOPPERS.COM, November 02, 2010 ) Point Roberts, WA - The Consolidated
investment Analysis on
Johnson & Johnson (NYSE:JNJ) will be in particular interest to other competing companies within in its sector, such as
Merck & Co. (NYSE: MRK),
Pfizer Inc. (NYSE: PFE) and
GlaxoSmithKline plc. (NYSE: GSK)
Point Roberts, WA - Chartpoppers.com announces an investment report featuring company Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. Johnson & Johnson has more than 250 operating companies. The Company operates in three segments. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women's healthcare fields, as well as nutritional and over-the-counter pharmaceutical products.
To view the Consolidated Investment Analysis on Johnson & Johnson (NYSE:JNJ) Please visit the stock pulse page at
http://www.chartpoppers.com
In the report chartpoppers.com covers a recent Financial Summary, Analyst Consensus, Technical Analysis, Comparative Analysis and Insider Trading Activity.
The full report is available at
http://www.chartpoppers.com
Chartpoppers.com is a market research and investment commentary provider. Chartpoppers.com aims to bring undervalued, up and coming companies into the sight of both experienced and non-experienced investors. We try to help investors, at whatever stage in their careers, to get a grasp on the necessary financial data that they need in order to make a educated investment decision. From our daily trading ideas to a in depth coverage of what's going on in the markets, we are sure that chartpoppers.com is exactly what you need in order succeed.
For More information please visit us at
http://www.chartpoppers.com
Chartpoppers.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. ChartPoppers.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
CHARTPOPPERS.COM
Paul Marek
6047245332
info@chartpoppers.comSource:
EmailWire.Com
